Newsroom

HOUSTON--(BUSINESS WIRE)--SynergenX, the veteran-owned leader in provider-led, personalized hormone and wellness medicine, is launching a bold New Year 2026 campaign designed to make hormone testing, wellness care, and medical weight loss more accessible across the SynergenX network clinics, including Low T Center and HerKare. Built around the belief that better healthcare starts with access, the initiative brings together comprehensive testing, board-certified provider consultations, and inten...

DUBLIN--(BUSINESS WIRE)--The "Medical Devices: Developing Effective Post Market Surveillance and Complaint Handling Systems Course (Jan 22nd - Jan 23rd, 2026)" training has been added to ResearchAndMarkets.com's offering. What are U.S. FDA CGMP expectations/requirements for Post Market Surveillance and Complaint Handling? This seminar will examine Section 522 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), as well as appropriate articles / Annexes of the EU's MDR, which require manu...

DUBLIN--(BUSINESS WIRE)--The "Statistical Process Control (SPC): An Exercise-Based Training Course (February 6, 2026)" training has been added to ResearchAndMarkets.com's offering. This course provides an in-depth understanding of Statistical Process Control (SPC), a key methodology used in quality management to monitor, control, and improve process performance. This 6-hour virtual seminar includes a presentation of the steps and techniques used to quantify variability in manufacturing processe...

BOSTON--(BUSINESS WIRE)--MassNAELA) applauds report by ALR Commission outlining recommendations to improve health and safety standards at state's assisted living facilities....

DUBLIN--(BUSINESS WIRE)--The "Metamaterials Market, Till 2035: Distribution by Type of Metamaterial, Product Form, Application, Type of Enterprise, End Use Industry and Geographical Regions" has been added to ResearchAndMarkets.com's offering. The global metamaterials market is projected to escalate from USD 1.55 billion today to USD 17.44 billion by 2035, growing at a robust CAGR of 27.36%. Originally hindered by the limitations of traditional metals, the metamaterial revolution notably enhanc...

DUBLIN--(BUSINESS WIRE)--The "RNA Sequencing Service Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Sequencing Method, Application Area, End User Industry and Key Geographical Regions" has been added to ResearchAndMarkets.com's offering. The RNA sequencing service market is predicted to experience substantial growth, climbing from USD 3.3 billion in 2023 to USD 7.5 billion by 2035, with a compound annual growth rate (CAGR) of 8.4%. As an essential technique fo...

MORRISVILLE, Caroline du Nord--(BUSINESS WIRE)--WEP Clinical (WEP), une organisation de recherche sous contrat (ontract research organization, CRO) à services complets, vient d’annoncer l’acquisition de Siron Clinical (Siron), une CRO européenne basée aux Pays-Bas, spécialisée dans les opérations cliniques flexibles et de haute qualité pour les entreprises de biotechnologie. Cette acquisition permet à WEP d’élargir sa présence mondiale et de renforcer sa capacité à fournir des solutions complèt...

米ノースカロライナ州モリスビル--(BUSINESS WIRE)--（ビジネスワイヤ） -- フルサービスのCRO（開発業務受託機関）であるWEPクリニカル（WEP）は、バイオテクノロジー企業向けに柔軟かつ高品質な臨床オペレーションを専門とするオランダに拠点を置く欧州CROシロン・クリニカル（シロン）の買収を発表しました。これにより、WEPのグローバル展開が拡大するとともに、複雑、希少、専門性の高い治療領域におけるエンドツーエンドの第I相～IV相臨床試験ソリューションの提供能力が強化されます。 2000年に設立されたシロンは、オランダに本社を置き、ベルギーとドイツにもオフィスを構え、ヨーロッパと中東に臨床研究の専門家を擁しています。同社は、プロジェクト管理、臨床モニタリング、品質保証、薬事申請などの臨床オペレーションを専門としています。シロンは120件以上の研究を支援しており、希少疾患、小児研究、医療機器試験において優れた実績を誇ります。 WEPの創業者兼CEO、ジャスウィンダー・ケラのコメント： 「今回の買収は、当社のCROサービスの進化における重要なマイルストーンとなります。WE...

MORRISVILLE, N.C.--(BUSINESS WIRE)--WEP Clinical (WEP), una organización de investigación por contrato (CRO) de servicio completo, anunció la incorporación de Siron Clinical (Siron), una CRO europea con sede en los Países Bajos especializada en operaciones clínicas flexibles y de alta calidad para empresas de biotecnología. Esta adquisición amplía la presencia global de WEP y fortalece su capacidad para ofrecer soluciones integrales para ensayos clínicos de Fase I a IV en áreas terapéuticas com...

MORRISVILLE, N.C.--(BUSINESS WIRE)--WEP Clinical (WEP), un'organizzazione di ricerca a contratto (CRO) che offre servizi completi, annuncia l'acquisizione di Siron Clinical (Siron), una CRO europea con sede nei Paesi Bassi, specializzata in attività cliniche flessibili e ad alta qualità per aziende biotecnologiche. L'acquisizione amplia la presenza globale di WEP e rafforza la sua capacità di realizzare soluzioni complete per studi clinici di fase I-IV in aree terapeutiche complesse, rare e spe...